Literature DB >> 21406333

Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytes.

Mark Ballow1, Cheryl Allen.   

Abstract

Intravenous immunoglobulin (IgIV) has immune modulating effects on the differentiation and function of dendritic cells (DC). Peripheral blood CD14+ monocytes were induced to differentiate into immature DC with IL-4/GM-CSF. DC maturation was analyzed by flow cytometry, and function assessed for antigen uptake and antigen processing. IgIV added during the differentiation process induced immature DC to differentiate into a mature DC with increased expression of CD83 and CCR7. A "priming" step with low concentrations of LPS or other TLR agonists that utilize the myD88 signaling pathway was necessary to observe these changes. These modulated DCs had reduced antigen uptake, but exhibited increased antigen presentation. Treatment of the IgIV with pepsin to generate F(ab')2 fragments abrogated these effects on DC maturation and function. The enhanced differentiation of PBM into DC required two signals: an initial exposure to low concentrations of LPS followed by IVIG. The second signal with IVIG was Fc dependent.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21406333     DOI: 10.1016/j.clim.2011.02.006

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  7 in total

Review 1.  IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids.

Authors:  Mark B Jones
Journal:  Cell Immunol       Date:  2018-03-31       Impact factor: 4.868

2.  Intravenous immunoglobulin (IVIg) dampens neuronal toll-like receptor-mediated responses in ischemia.

Authors:  Ker Zhing Lok; Milan Basta; Silvia Manzanero; Thiruma V Arumugam
Journal:  J Neuroinflammation       Date:  2015-04-15       Impact factor: 8.322

3.  An fc gamma receptor-mediated upregulation of the production of interleukin 10 by intravenous immunoglobulin in bone-marrow-derived mouse dendritic cells stimulated with lipopolysaccharide in vitro.

Authors:  Akihiro Fujii; Yuko Kase; Chiaki Suzuki; Akihito Kamizono; Teruaki Imada
Journal:  J Signal Transduct       Date:  2013-06-18

4.  Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway.

Authors:  Andrew R Crow; Honghui Yu; Dongji Han; Alan H Lazarus
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

5.  The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease.

Authors:  Rolf Spirig; Janice Tsui; Sidney Shaw
Journal:  Cardiol Res Pract       Date:  2012-04-22       Impact factor: 1.866

6.  IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID.

Authors:  Dominic Paquin-Proulx; Bianca A N Santos; Karina I Carvalho; Myrthes Toledo-Barros; Ana Karolina Barreto de Oliveira; Cristina M Kokron; Jorge Kalil; Markus Moll; Esper G Kallas; Johan K Sandberg
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

7.  Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens.

Authors:  José-María Díez; Carolina Romero; Rodrigo Gajardo
Journal:  Immunotherapy       Date:  2020-05-12       Impact factor: 4.196

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.